CORCEPT THERAPEUTICS INC 4

Insider James N. Wilson, via a family trust, sold 10,000 shares of Corcept Therapeutics Inc. (CORT) common stock on July 15, 2026 under a 10b5-1 plan for approximately $878,000 in total proceeds.

On July 15, 2026, reporting person James N. Wilson, through the James N. Wilson and Pamela D. Wilson Trust, executed a series of automatic Rule 10b5-1 plan sales of Corcept Therapeutics Inc. common stock, selling an aggregate 10,000 shares in four tranches at weighted average prices ranging from approximately $86.78 to $89.49 per share, for total proceeds of roughly $878,000. Following these transactions, the trust’s directly reported holdings stood at 1,084,543 shares, and Wilson also has indirect interests in an additional 200,000 Corcept shares held by each of the James N. Wilson 2025 Grantor Retained Annuity Trust and the Pamela D. Wilson 2025 Grantor Retained Annuity Trust, over which he has voting power but disclaims beneficial ownership except to the extent of his pecuniary interest.

Filing Facts

CIK

1088856

Ticker

CORT

Form

4

Source Type

fda

Accession

0001193125-26-308061

Alert Tier

6